CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 170 filers reported holding CLOVIS ONCOLOGY INC in Q4 2018. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $34,000 | -39.3% | 12,600 | 0.0% | 0.00% | -50.0% |
Q3 2021 | $56,000 | -23.3% | 12,600 | 0.0% | 0.00% | -33.3% |
Q2 2021 | $73,000 | -34.8% | 12,600 | -21.2% | 0.00% | -40.0% |
Q1 2021 | $112,000 | -87.7% | 16,000 | -91.6% | 0.01% | -85.7% |
Q4 2020 | $910,000 | -17.6% | 189,533 | 0.0% | 0.04% | -32.7% |
Q3 2020 | $1,104,000 | -13.8% | 189,533 | 0.0% | 0.05% | -28.8% |
Q2 2020 | $1,280,000 | -0.9% | 189,533 | -6.7% | 0.07% | -28.4% |
Q1 2020 | $1,292,000 | -46.6% | 203,100 | -12.6% | 0.10% | -23.9% |
Q4 2019 | $2,419,000 | +385.7% | 232,400 | +83.0% | 0.13% | +318.8% |
Q3 2019 | $498,000 | -54.3% | 127,000 | +73.3% | 0.03% | -49.2% |
Q2 2019 | $1,090,000 | +18.9% | 73,300 | +98.1% | 0.06% | +14.5% |
Q1 2019 | $917,000 | +168.9% | 37,000 | +94.7% | 0.06% | +139.1% |
Q4 2018 | $341,000 | -67.7% | 19,000 | -47.2% | 0.02% | -48.9% |
Q3 2018 | $1,057,000 | +484.0% | 36,013 | +800.3% | 0.04% | +462.5% |
Q2 2018 | $181,000 | -87.4% | 4,000 | -85.3% | 0.01% | -88.9% |
Q1 2018 | $1,436,000 | -57.8% | 27,200 | -45.6% | 0.07% | -57.1% |
Q4 2017 | $3,400,000 | -23.3% | 50,000 | -7.1% | 0.17% | -22.2% |
Q3 2017 | $4,432,000 | -11.9% | 53,800 | +0.2% | 0.22% | -11.5% |
Q2 2017 | $5,028,000 | +18.9% | 53,700 | -19.1% | 0.24% | -3.6% |
Q1 2017 | $4,227,000 | +68.1% | 66,400 | +17.2% | 0.25% | +84.7% |
Q4 2016 | $2,515,000 | +1097.6% | 56,632 | +843.9% | 0.14% | +1041.7% |
Q4 2015 | $210,000 | – | 6,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 3,402,781 | $231,389,000 | 9.96% |
Versant Venture Management, LLC | 101,855 | $6,926,140,000 | 7.29% |
Avoro Capital Advisors LLC | 1,102,884 | $74,996,000 | 4.86% |
Redmile Group, LLC | 1,320,027 | $89,762,000 | 3.90% |
NEXTHERA CAPITAL LP | 233,200 | $15,858,000 | 2.92% |
Iguana Healthcare Management, LLC | 60,000 | $4,080,000 | 2.66% |
HealthCor Management, L.P. | 973,840 | $66,221,000 | 2.16% |
Casdin Capital, LLC | 127,500 | $8,670,000 | 2.11% |
Prosight Management, LP | 40,000 | $2,720,000 | 2.00% |
Camber Capital Management LP | 600,000 | $40,800,000 | 2.00% |